Company Search:
Advanced Search
Sponsored Links
Transgene Company Snapshot
Transgene operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Transgene with three other pharmaceutical manufacturers in Europe: Biomed Lublin Wytwornia Surowic I Szczepionek SA of Poland (2015 sales of 42.59 million Polish New Zlotys [US$10.45 million] ), Co Don AG of Germany (5.09 million Euro [US$5.45 million] of which 100% was Product sales), and Curasan AG which is also based in Germany (5.62 million Euro [US$6.02 million] ).

Sales Analysis. During the year ended December of 2015, sales at Transgene were 9.57 million Euro (US$10.25 million). This is a decrease of 18.6% versus 2014, when the company's sales were 11.75 million Euro. Contributing to the drop in overall sales was the 55.5% decline in Research and Development Subsidies, from 551,000.00 Euro to 245,000.00 Euro. There were also decreases in sales in Research and Development Tax Credit (down 9.8% to 7.86 million Euro) and Bio-Production and Cooperations (down 52.2% to 798,000.00 Euro) and Royalties and Licenses (down 18.9% to 667,000.00 Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for Transgene
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 2.70
(Figures in Euro)
1 Week -5.9%   13 Weeks -0.4%  
4 Weeks -8.7%   52 Weeks -11.9%  
Transgene Key Data:
  Ticker: TNG Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 9,565,000
(Year Ending Jan 2016).
Employees: 266
  Currency: Euro Market Cap: 106,304,868
  Fiscal Yr Ends: December Shares Outstanding: 39,372,173
  Share Type: Actions Ordinaires Closely Held Shares: 35,747,838
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.